ロード中...
Long-term donepezil use for dementia with Lewy bodies: results from an open-label extension of Phase III trial
INTRODUCTION: The long-term efficacy and safety of donepezil 10 mg in patients with dementia with Lewy bodies (DLB) were investigated in a 52-week Phase 3 trial. METHODS: This 52-week study consisted of 16-week randomized placebo-controlled (RCT) and 36-week open-label extension phases. Of 142 DLB p...
保存先:
| 出版年: | Alzheimers Res Ther |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4338564/ https://ncbi.nlm.nih.gov/pubmed/25713600 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-014-0081-2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|